2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections

por Hart, Delaney E, Gallagher, Jason C, Puzniak, Laura A, Hirsch, Elizabeth B, Hirsch, Elizabeth B
Publicado 2019

1438. Escherichia coli (EC) ST131-H30 Clonal Group is Associated with Antimicrobial Resistance, Illness Severity, Host Compromise, and Non-Cure among Patients with Bacteriuria

por Mahoney, Melanie T, Brigman, Hunter V, Johnston, Brian, Raux, Brian R, Johnson, James R, Hirsch, Elizabeth B, Hirsch, Elizabeth B
Publicado 2019

1661. Evaluation of Cefazolin < 3 g vs. 3 g Treatment Doses for Cellulitis in Patients Who Weigh ≥ 120 kg within a Large, Community Health System

por Gens, Krista, Wankum, Michael, Hirsch, Elizabeth B, Gagnon, Brandon
Publicado 2022

1753. Impact of a Pharmacist-Driven Home Hospital Antimicrobial Stewardship Program Pilot within a Large Community Health System

por Nguyen, Van, Wankum, Michael, Gens, Krista, Hirsch, Elizabeth B
Publicado 2022

2164. Activity of Fosfomycin (FOF) and Frequency of Nonsusceptible Inner Colonies During Susceptibility Testing of an International Collection of Clinical Pseudomonas aeruginosa (P...

por Smith, Elizabeth C, Brigman, Hunter V, Anderson, Jadyn C, Emery, Christopher L, Bias, Tiffany E, Landersdorfer, Cornelia B, Bergen, Phillip J, Hirsch, Elizabeth B, Hirsch, Elizabeth B
Publicado 2019

2959. Urinary tract colonizing abilities of fosfomycin (FOF) non-susceptible Klebsiella pneumoniae (KP) inner colonies (IC) arising from disk diffusion (DD) in an ascending mouse u...

por Bixby, Morgan, Collins, Lindsey, Salay, Jenna, Clabots, Connie, Hirsch, Elizabeth B
Publicado 2023

572. Growth rate comparisons for clinical Klebsiella pneumoniae (KP) isolates using nutrient-rich and -depleted broth stratified by inner colony production during fosfomycin (FOF)...

por Daley, Ellora, Bixby, Morgan, Collins, Lindsey, Salay, Jenna, Hirsch, Elizabeth B
Publicado 2023

Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections

por Giancola, Stephanie E, Mahoney, Monica V, Bias, Tiffany E, Hirsch, Elizabeth B
Publicado 2016

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections

por Hart, Delaney E, Gallagher, Jason C, Puzniak, Laura A, Hirsch, Elizabeth B
Publicado 2021

The antimicrobial peptide DGL13K is active against drug-resistant gram-negative bacteria and sub-inhibitory concentrations stimulate bacterial growth without causing resistance

por Gorr, Sven-Ulrik, Brigman, Hunter V., Anderson, Jadyn C., Hirsch, Elizabeth B.
Publicado 2022

Retrospective cohort analysis of the safety of outpatient parenteral antimicrobial therapy (OPAT) in an academic hospital

por Billmeyer, Kaylyn, Galdys, Alison, Kline, Susan, Hirsch, Elizabeth, Ross, Jennifer, Evans, Michael
Publicado 2022

Activity of Ceftolozane/tazobactam (C/T) and Ceftazidime/avibactam (CZA) against Extended-spectrum Β-lactamase (ESBL)-producing Enterobacteriaceae and Multidrug-resistant (MDR) Pse...

por Hirsch, Elizabeth B, Zucchi, Paola, Cheung, Nicole, Krevolin, Kyle, Emery, Christopher, Bias, Tiffany
Publicado 2017

The Activity of Antimicrobial Surfaces Varies by Testing Protocol Utilized

por Campos, Matias D., Zucchi, Paola C., Phung, Ann, Leonard, Steven N., Hirsch, Elizabeth B.
Publicado 2016

219. Characteristics Associated with Inappropriate Antibiotic Prescribing in Patients with Asymptomatic Bacteriuria (ASB)

por Bixby, Morgan L, Raux, Brian R, Bhalla, Aakansha, McCoy, Christopher, Hirsch, Elizabeth B
Publicado 2020

Opportunities for antibiotic stewardship in emergency department or hospitalized patients with asymptomatic bacteriuria: identifying risk factors for antibiotic treatment

por Bixby, Morgan L., Raux, Brian R., Bhalla, Aakansha, McCoy, Christopher, Hirsch, Elizabeth B.
Publicado 2022

1758. Retrospective cohort analysis of outcomes in patients receiving outpatient parenteral antibiotic therapy (OPAT)

por Billmeyer, Kaylyn, Ross, Jennifer, Hirsch, Elizabeth B, Evans, Michael, Kline, Susan E, Galdys, Alison
Publicado 2022

Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommend...

por Bixby, Morgan L., Salay, Jenna M., Krueger, Amanda R., Mathers, Amy J., Hirsch, Elizabeth B.
Publicado 2023

Surface Microbiology of the iPad Tablet Computer and the Potential to Serve as a Fomite in Both Inpatient Practice Settings as Well as Outside of the Hospital Environment

por Hirsch, Elizabeth B., Raux, Brian R., Lancaster, Jason W., Mann, Rachael L., Leonard, Steven N.
Publicado 2014

133. Creation of an Emergency Department (ED)-Specific Urine Antibiogram and Evaluation of Urinary Tract Infection (UTI) Prescribing Practices at a Tertiary Academic Medical Center

por Broadbent, Eleanor K, Caitlin, Schanz, Boeser, Kimberly D, Mason, Jocelyn, Norton, Laura E, Hirsch, Elizabeth B
Publicado 2020

2880. Propensity score-weighted analysis of the impact of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation on unscheduled care

por Sieling, William D, Ross, Jennifer, Evans, Michael, Billmeyer, Kaylyn, Hirsch, Elizabeth B, Kline, Susan E, Galdys, Alison
Publicado 2023